554 related articles for article (PubMed ID: 31471945)
1. The cell of origin and the leukemia stem cell in acute myeloid leukemia.
Chopra M; Bohlander SK
Genes Chromosomes Cancer; 2019 Dec; 58(12):850-858. PubMed ID: 31471945
[TBL] [Abstract][Full Text] [Related]
2. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
[TBL] [Abstract][Full Text] [Related]
3. Differential niche and Wnt requirements during acute myeloid leukemia progression.
Lane SW; Wang YJ; Lo Celso C; Ragu C; Bullinger L; Sykes SM; Ferraro F; Shterental S; Lin CP; Gilliland DG; Scadden DT; Armstrong SA; Williams DA
Blood; 2011 Sep; 118(10):2849-56. PubMed ID: 21765021
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
5. [Progress in the studies of acute myelogenous leukemia stem cell].
Cui JW; Zhang XM; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):549-52. PubMed ID: 14575558
[TBL] [Abstract][Full Text] [Related]
6. Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.
Moshaver B; Wouters RF; Kelder A; Ossenkoppele GJ; Westra GAH; Kwidama Z; Rutten AR; Kaspers GJL; Zweegman S; Cloos J; Schuurhuis GJ
Leuk Res; 2019 Jun; 81():27-34. PubMed ID: 31002948
[TBL] [Abstract][Full Text] [Related]
7. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Abnormalities in Acute Myeloid Leukemia and Leukemia Stem Cells.
Xu J; Hang X; Wu B; Chen C; Liu Y
Adv Exp Med Biol; 2019; 1143():173-189. PubMed ID: 31338820
[TBL] [Abstract][Full Text] [Related]
9. IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis.
Verhagen HJMP; van Gils N; Martiañez T; van Rhenen A; Rutten A; Denkers F; de Leeuw DC; Smit MA; Tsui ML; de Vos Klootwijk LLE; Menezes RX; Çil M; Roemer MGM; Vermue E; Heukelom S; Zweegman S; Janssen JJWM; Ossenkoppele GJ; Schuurhuis GJ; Smit L
Cell Rep; 2018 Dec; 25(11):3021-3035.e5. PubMed ID: 30540936
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia stem cells.
Dick JE
Ann N Y Acad Sci; 2005 Jun; 1044():1-5. PubMed ID: 15958691
[TBL] [Abstract][Full Text] [Related]
11. Modeling Leukemia Stem Cells with Patient-Derived Induced Pluripotent Stem Cells.
Deslauriers AG; Kotini AG; Papapetrou EP
Methods Mol Biol; 2021; 2185():411-422. PubMed ID: 33165864
[TBL] [Abstract][Full Text] [Related]
12. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
[TBL] [Abstract][Full Text] [Related]
13. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
Marchand T; Pinho S
Front Immunol; 2021; 12():775128. PubMed ID: 34721441
[TBL] [Abstract][Full Text] [Related]
14. Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes.
Yanagisawa B; Perkins B; Karantanos T; Levis M; Ghiaur G; Smith BD; Jones RJ
Leuk Res; 2020 Dec; 99():106477. PubMed ID: 33220589
[TBL] [Abstract][Full Text] [Related]
15. TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia.
Kikushige Y; Akashi K
Ann N Y Acad Sci; 2012 Aug; 1266():118-23. PubMed ID: 22901263
[TBL] [Abstract][Full Text] [Related]
16. Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics.
Velten L; Story BA; Hernández-Malmierca P; Raffel S; Leonce DR; Milbank J; Paulsen M; Demir A; Szu-Tu C; Frömel R; Lutz C; Nowak D; Jann JC; Pabst C; Boch T; Hofmann WK; Müller-Tidow C; Trumpp A; Haas S; Steinmetz LM
Nat Commun; 2021 Mar; 12(1):1366. PubMed ID: 33649320
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia.
Ye M; Zhang H; Yang H; Koche R; Staber PB; Cusan M; Levantini E; Welner RS; Bach CS; Zhang J; Krivtsov AV; Armstrong SA; Tenen DG
Cell Stem Cell; 2015 Nov; 17(5):611-23. PubMed ID: 26412561
[TBL] [Abstract][Full Text] [Related]
18. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
[TBL] [Abstract][Full Text] [Related]
19. The role of exosomes in the stemness maintenance and progression of acute myeloid leukemia.
Li Q; Wang M; Liu L
Biochem Pharmacol; 2023 Jun; 212():115539. PubMed ID: 37024061
[TBL] [Abstract][Full Text] [Related]
20. TIM-3 in normal and malignant hematopoiesis: Structure, function, and signaling pathways.
Kikushige Y
Cancer Sci; 2021 Sep; 112(9):3419-3426. PubMed ID: 34159709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]